News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
resultados Admit Therapeutics
ADmit Therapeutics predicts progression to Alzheimer's dementia 14 years in advance
Healthcare · Advanced therapies
Partners - ADmit Therapeutics
Parc cientific Maria Terrades
The public ecosystem of the Barcelona Science Park raises 70 million euros in 2023, 40% more than in 2022
Healthcare · Access to innovation · Industrial biotechnology · International · Financing · Talento
These data consolidate the Barcelona Science Park as one of the most powerful hubs for public…
Partners - Parc Científic de Barcelona
Alfons Carnicero
"ABLE Human Motion was created almost 6 years ago with the vision of democratising robotic exoskeletons. After launching the product for clinical use we are now working on a new robotic exoskeleton for private use"
Healthcare · Access to innovation · Personalized medicine · Financing · Talento · Corporate
Partners - GENESIS Biomed
logo final
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
Healthcare · Access to innovation · Innovative drugs
Partners - THERIVA BIOLOGICS S.L.
ceo quibim
La IA ayuda a los radiólogos a detectar más del 90% de cáncer de próstata en España
Healthcare · Access to innovation
 Spanish company Quibim's QP-Prostate solution, which uses biopsy and MRI data for training,…
Partners - Quibim SL
agarose bead
Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market
Communication · Corporate
Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production…
Partners - Agarose Bead Technologies (ABT)
arthex biotech
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
Healthcare · Innovative drugs
ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1
Partners - ARTHEx Biotech
Oryzon sede
ORYZON announces formal grant of key European patent for vafidemstat
Healthcare · Innovative drugs · International · EU projects
For the treatment of aggression and social withdrawal. 
Partners - Oryzon Genomics
Aprobación ensayo citoquinas Peaches
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
  Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will…
Partners - PEACHES BIOTECH S.L.